3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
32
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Carcinoma, Ovarian Epithelial
3
Pancreatic Neoplasms
2
Lung Neoplasms
2
Kidney Neoplasms
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms, Male
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Solid Malignancies
1
Sarcoma
1
Recurrent Uterine Corpus Sarcoma
1
Recurrence
1
Pain
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Adenocarcinoma
1
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Vincristine
4
Nuclear Medicine Department, Hospital
4
Doxorubicin
4
Dactinomycin
4
Radiotherapy
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Radiotherapy, Conformal
2
Radiation
2
LY3023414
2
Etoposide
2
Cyclophosphamide
2
Carboplatin
2
thymoglobulin
1
sargramostim
1
pembrolizumab
1
lorvotuzumab mertansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Wilms Tumor
×
ixabepilone
×
Clear all
No trials found.